Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hashimoto

Showing results (1291-1300 of 1,304) with videos related to

Pageof 131
Sort By:
Reproduction (Cambridge, England)|November 5, 2017
Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient miceD Reglodi, S Cseh, B Somoskoi, et al.
British Journal of Cancer|June 10, 2004
DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinomaY Ebihara, M Miyamoto, A Fukunaga, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout miceK Miyawaki, Y Yamada, H Yano, et al.
Clinical Hemorheology and Microcirculation|September 21, 2001
Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver diseaseT Kurihara, S Deguchi, J Kato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE studyK Suzuki, T Yamanaka, H Hashimoto, et al.
Journal of Molecular Neuroscience : MN|April 25, 2012
PACAP is an endogenous protective factor-insights from PACAP-deficient miceD Reglodi, P Kiss, K Szabadfi, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 25, 2009
Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient miceH Hashimoto, T Arai, A Mori, et al.
ESMO Open|July 10, 2026
First-in-human phase I study of hypoxia-targeting <sup>64</sup>Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64)H Kurihara, Y Narita, K Ito, et al.
Neuroscience|April 6, 2015
Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptideY Shibasaki, A Hayata-Takano, K Hazama, et al.
Molecular Psychiatry|March 28, 2007
Pituitary adenylate cyclase-activating polypeptide is associated with schizophreniaR Hashimoto, H Hashimoto, N Shintani, et al.
Pageof 131

Showing results (1291-1300 of 1,304) with videos related to

Sort By:
Pageof 131
Reproduction (Cambridge, England)|November 5, 2017
Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient miceD Reglodi, S Cseh, B Somoskoi, et al.
British Journal of Cancer|June 10, 2004
DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinomaY Ebihara, M Miyamoto, A Fukunaga, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout miceK Miyawaki, Y Yamada, H Yano, et al.
Clinical Hemorheology and Microcirculation|September 21, 2001
Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver diseaseT Kurihara, S Deguchi, J Kato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE studyK Suzuki, T Yamanaka, H Hashimoto, et al.
Journal of Molecular Neuroscience : MN|April 25, 2012
PACAP is an endogenous protective factor-insights from PACAP-deficient miceD Reglodi, P Kiss, K Szabadfi, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 25, 2009
Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient miceH Hashimoto, T Arai, A Mori, et al.
ESMO Open|July 10, 2026
First-in-human phase I study of hypoxia-targeting <sup>64</sup>Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64)H Kurihara, Y Narita, K Ito, et al.
Neuroscience|April 6, 2015
Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptideY Shibasaki, A Hayata-Takano, K Hazama, et al.
Molecular Psychiatry|March 28, 2007
Pituitary adenylate cyclase-activating polypeptide is associated with schizophreniaR Hashimoto, H Hashimoto, N Shintani, et al.
Pageof 131